Vaccines, antibodies and therapeutic proteins are currently produced in bacteria and yeast (microbes), in mammalian and insect cell culture and in transgenic animals. Influenza vaccines are produced in millions of fertilized chicken eggs, taking up to six months, which makes it difficult to react to mutating virus strains and limits the amount that can be produced each flu season. The iBioLaunch™ platform has significant advantages over current production methods, and over systems being developed in transgenic plants: |